Halma plc (LON:HLMA – Get Free Report) has received an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is GBX 3,455.
A number of equities research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft increased their price target on shares of Halma from GBX 3,290 to GBX 3,690 and gave the stock a “hold” rating in a report on Friday, October 3rd. Peel Hunt reaffirmed a “buy” rating and set a GBX 3,750 target price on shares of Halma in a report on Thursday. The Goldman Sachs Group initiated coverage on shares of Halma in a report on Thursday, August 7th. They issued a “buy” rating and a GBX 3,740 price target for the company. Shore Capital restated a “hold” rating on shares of Halma in a research report on Friday, September 26th. Finally, Berenberg Bank increased their price objective on Halma from GBX 3,250 to GBX 3,750 and gave the stock a “buy” rating in a research report on Wednesday, September 10th.
Check Out Our Latest Stock Report on Halma
Halma Trading Down 2.2%
Insider Buying and Selling at Halma
In other news, insider Jennifer Ward sold 15,000 shares of Halma stock in a transaction dated Thursday, September 25th. The stock was sold at an average price of GBX 3,381, for a total transaction of £507,150. 0.81% of the stock is currently owned by insiders.
Halma Company Profile
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:
– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.
Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.
See Also
- Five stocks we like better than Halma
- The Risks of Owning Bonds
- MP Materials Stock Soared After Earnings—Here’s the Real Reason
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Why Palantir Slide May Be a Setup for a Long-Term Opportunity
- What is the S&P/TSX Index?
- Attention Income Investors: This REIT Is on Sale
Receive News & Ratings for Halma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halma and related companies with MarketBeat.com's FREE daily email newsletter.
